TNF-Related Apoptosis-Inducing Ligand Receptor 1 in Patients With Ankylosing Spondylitis

Karadag D., Tekeoglu S., Yazici A., Isik O., Eraldemir F. C., Cefle A.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, vol.26, no.6, pp.242-247, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 6
  • Publication Date: 2020
  • Doi Number: 10.1097/rhu.0000000000001050
  • Journal Name: JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.242-247
  • Keywords: TNF-related apoptosis-inducing ligand receptor 1, TNF-alpha, ankylosing spondylitis, INCREASED EXPRESSION, TRAIL, CYTOKINES, THERAPY
  • Kocaeli University Affiliated: Yes

Abstract

Objectives: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) belongs to the tumor necrosis factor (TNF) superfamily and is reported to play a role in autoimmune diseases. In this study, we aimed to measure serum TRAIL receptor 1 (TRAIL-R1) concentration and assess any phenotypic relationship in patients with ankylosing spondylitis (AS).